{"id":30543,"date":"2026-02-04T21:39:40","date_gmt":"2026-02-04T21:39:40","guid":{"rendered":"https:\/\/progyny.com\/?p=30543"},"modified":"2026-02-04T21:39:40","modified_gmt":"2026-02-04T21:39:40","slug":"raising-the-bar-for-transparency-and-personalization-in-fertility-care","status":"publish","type":"post","link":"https:\/\/progyny.com\/blog\/raising-the-bar-for-transparency-and-personalization-in-fertility-care\/","title":{"rendered":"Raising the bar for transparency and personalization in fertility care"},"content":{"rendered":"\n

By Janet Choi, MD, Chief Medical Officer at Progyny<\/em><\/p>\n\n\n\n

For most of us, the beginning of a new year is a time of both reflection and renewal. It\u2019s a moment to take stock \u2014 as individuals, companies, and industries \u2014 of how far we\u2019ve come, what we\u2019ve learned and achieved, and to set new intentions for the year ahead.<\/p>\n\n\n\n

In that spirit, I\u2019d like to start this year with a call to action for all of us across the fertility and family-building ecosystem: to do better for those affected by infertility who want nothing more than the chance to build a healthy family.<\/p>\n\n\n\n

Doing better means optimizing and personalizing the care journey for every individual and every family. Infertility is not a single pathway or a uniform experience. Each journey carries its own emotional, physical, and financial weight \u2014 and the care we deliver should reflect that reality. To truly personalize care, every clinical decision must be grounded in evidence, supported by data, and informed by outcomes we can trust.<\/p>\n\n\n\n

But like all resolutions, following through requires more than good intentions. It requires rigorous data collection, transparent reporting, and shared benchmarks. It requires consistent clinical standards \u2014 and industry-wide accountability to those standards.<\/p>\n\n\n\n

Last year, we published our annual, third-party-validated fertility outcomes report<\/a>, continuing a decade-long commitment to openly sharing how our solutions perform for our members and employers. Once again, the data showed that Progyny significantly exceeds national benchmarks across key clinical measures of fertility success. But beyond the results themselves, there was a deeper message \u2014 one that feels especially salient as we consider where our industry needs to go next:<\/p>\n\n\n\n

Because every outcome matters, how we measure and report those outcomes matters just as much.<\/h2>\n\n\n\n

For the 1 in 6<\/a> individuals affected by infertility, the path to parenthood can be emotionally draining, physically demanding, and financially burdensome. That journey requires an extraordinary level of trust \u2014 trust from members that their benefits partner is committed to the highest standards of care and outcomes, and trust from employers that their investment is delivering meaningful, cost-effective impact for their workforce.<\/p>\n\n\n\n

Earning that trust depends on rigor and transparency. Yet today, standards for collecting and reporting IVF outcomes still vary widely. Some solutions rely on self-reported or selectively sampled data. Others use timelines or denominators that diverge from those established by CDC and SART, making apples-to-apples comparisons difficult and obscuring what results truly mean at scale.<\/p>\n\n\n\n

Some variation in standards is expected in a field that has evolved as rapidly as fertility benefits in recent years. Nevertheless, we can \u2014 and must \u2014 do better.<\/p>\n\n\n\n

If, as an industry, we truly want to personalize fertility care for all, we need shared expectations for outcomes reporting grounded in common standards:<\/p>\n\n\n\n